Find Amrinone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 60719-84-8, Inamrinone, Wincoram, Inocor, Cordemcura, Cartonic
Molecular Formula
C10H9N3O
Molecular Weight
187.20  g/mol
InChI Key
RNLQIBCLLYYYFJ-UHFFFAOYSA-N
FDA UNII
JUT23379TN

Amrinone
A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
1 2D Structure

Amrinone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-amino-5-pyridin-4-yl-1H-pyridin-2-one
2.1.2 InChI
InChI=1S/C10H9N3O/c11-9-5-8(6-13-10(9)14)7-1-3-12-4-2-7/h1-6H,11H2,(H,13,14)
2.1.3 InChI Key
RNLQIBCLLYYYFJ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CN=CC=C1C2=CNC(=O)C(=C2)N
2.2 Other Identifiers
2.2.1 UNII
JUT23379TN
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5-amino-(3,4'-bipyridine)-6(1h)-one

2. Amrinon

3. Cordemcura

4. Inocor

5. Win 40680

6. Win-40680

7. Win40680

8. Wincoram

2.3.2 Depositor-Supplied Synonyms

1. 60719-84-8

2. Inamrinone

3. Wincoram

4. Inocor

5. Cordemcura

6. Cartonic

7. Amcoral

8. Amrinonum [inn-latin]

9. Vesistol

10. 5-amino-[3,4'-bipyridin]-6(1h)-one

11. Amrinona [inn-spanish]

12. 3-amino-5-(4-pyridinyl)-2(1h)-pyridinone

13. Win-40680

14. Win 40680

15. 3-amino-5-pyridin-4-yl-1h-pyridin-2-one

16. 5-amino-(3,4'-bipyridin)-6(1h)-one

17. Awd 08-250

18. [3,4'-bipyridin]-6(1h)-one, 5-amino-

19. Amrinone [inn]

20. 5-amino-3,4'-bipyridin-6(1h)-one

21. Amrinone Lactate

22. Mls000069829

23. 5-amino(3,4'-bipyridin)-6(1h)-one

24. Nsc-759805

25. (3,4'-bipyridin)-6(1h)-one, 5-amino-

26. Smr000058850

27. Chembl12856

28. Jut23379tn

29. C01ce01

30. 3-amino-5-pyridin-4-ylpyridin-2-ol

31. 3-amino-5-(pyridin-4-yl)pyridin-2-ol

32. 5-amino[3,4'-bipyridin]-6(1h)-one

33. Ncgc00164379-01

34. Amrinona

35. Amrinonum

36. Cas-60719-84-8

37. Dsstox_cid_2603

38. Dsstox_rid_76655

39. Dsstox_gsid_22603

40. Inamrinone (usp)

41. Amcoral (tn)

42. Ccris 3794

43. 3-amino-5-(pyridin-4-yl)pyridin-2(1h)-one

44. Amrinone (jan/inn)

45. Inamrinone [usan:usp]

46. Einecs 262-390-0

47. Brn 0744819

48. Unii-jut23379tn

49. Prestwick_44

50. Amrinone,(s)

51. Mfcd00083228

52. Spectrum_001350

53. Amrinone [jan]

54. Amrinone [mi]

55. Amrinone [vandf]

56. Opera_id_1054

57. Prestwick0_000800

58. Prestwick1_000800

59. Prestwick2_000800

60. Prestwick3_000800

61. Spectrum2_001980

62. Spectrum3_000956

63. Spectrum4_001069

64. Spectrum5_000999

65. Inamrinone [usan]

66. Amrinone [mart.]

67. Inamrinone [vandf]

68. Amrinone [usp-rs]

69. Amrinone [who-dd]

70. Cid_3698

71. Schembl44012

72. Bspbio_000940

73. Kbiogr_001398

74. Kbioss_001830

75. 5-25-15-00181 (beilstein Handbook Reference)

76. Mls001074083

77. Divk1c_000136

78. Spectrum1503084

79. Spbio_002139

80. Spbio_002879

81. Bpbio1_001034

82. Chebi:2686

83. Gtpl7202

84. Dtxsid9022603

85. Schembl13457017

86. Bdbm34651

87. Hms500g18

88. Kbio1_000136

89. Kbio2_001830

90. Kbio2_004398

91. Kbio2_006966

92. Kbio3_002052

93. Inamrinone [usp Impurity]

94. Ninds_000136

95. Hms1570o22

96. Hms2097o22

97. Hms2234f12

98. Hms3264e16

99. Hms3369j10

100. Hms3714o22

101. Inamrinone [usp Monograph]

102. Pharmakon1600-01503084

103. Bcp12764

104. Hy-b1294

105. Zinc8673078

106. Tox21_112110

107. Tox21_301847

108. Ccg-39487

109. Nsc759805

110. Stk590307

111. Akos005512516

112. Tox21_112110_1

113. Db01427

114. Ks-5178

115. Nsc 759805

116. Cid 5281003

117. Idi1_000136

118. Ncgc00016896-01

119. Ncgc00016896-02

120. Ncgc00016896-03

121. Ncgc00016896-04

122. Ncgc00016896-06

123. Ncgc00095984-01

124. Ncgc00255137-01

125. Ac-12186

126. Ac-33137

127. Ba166404

128. 5-amino(3,4'-bipyridine)-6-(1h)-one

129. 5-amino-(3,4?-bipyridin)-6(1h)-one

130. 3-amino-5-(4-pyridinyl)-2(1h)pyridinone

131. 3-azanyl-5-pyridin-4-yl-1h-pyridin-2-one

132. Cs-0013064

133. Ft-0601595

134. 5-amino-3,4'-bipyridyl-6(1h)-one

135. C75837

136. D00231

137. Ab00052312-04

138. Ab00052312_05

139. 3-amino-5-(4-pyridinyl)-1,2-dihydro-2-pyridone

140. 719a848

141. A832852

142. Q422724

143. Sr-00000002445

144. Sr-00000002445-2

145. W-105234

146. 3-amino-5-(pyridin-4-yl)-1,2-dihydropyridin-2-one

147. Brd-k45924332-001-04-4

148. Brd-k45924332-001-07-7

149. Amrinone, United States Pharmacopeia (usp) Reference Standard

150. 216151-27-8

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 187.20 g/mol
Molecular Formula C10H9N3O
XLogP3-0.2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count1
Exact Mass187.074561919 g/mol
Monoisotopic Mass187.074561919 g/mol
Topological Polar Surface Area68 Ų
Heavy Atom Count14
Formal Charge0
Complexity301
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Used in the treatment of congestive heart failure.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Amrinone is a positive inotropic cardiotonic with vasodilator properties, phosphodiesterase inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.


5.2 MeSH Pharmacological Classification

Calcium Channel Blockers

A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)


Vasodilator Agents

Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)


Cardiotonic Agents

Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)


Phosphodiesterase 3 Inhibitors

Compounds that specifically inhibit PHOSPHODIESTERASE 3. (See all compounds classified as Phosphodiesterase 3 Inhibitors.)


5.3 ATC Code

C - Cardiovascular system

C01 - Cardiac therapy

C01C - Cardiac stimulants excl. cardiac glycosides

C01CE - Phosphodiesterase inhibitors

C01CE01 - Amrinone


5.4 Absorption, Distribution and Excretion

Route of Elimination

The primary route of excretion in man is via the urine as both inamrinone and several metabolites (N-glycolyl, N-acetate, O-glucuronide and N-glucuronide).


Volume of Distribution

1.2 L/kg [normal volunteers]


5.5 Metabolism/Metabolites

Hepatic.


5.6 Biological Half-Life

5 to 8 hours


5.7 Mechanism of Action

Amrinone is a phosphodiesterase inhibitor (PDE3), resulting in increased cAMP and cGMP which leads to an increase in the calcium influx like that caused by beta-agonists resulting in increased inotropic effect.


Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Amrinone Manufacturers

A Amrinone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amrinone, including repackagers and relabelers. The FDA regulates Amrinone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amrinone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Amrinone Suppliers

A Amrinone supplier is an individual or a company that provides Amrinone active pharmaceutical ingredient (API) or Amrinone finished formulations upon request. The Amrinone suppliers may include Amrinone API manufacturers, exporters, distributors and traders.

click here to find a list of Amrinone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Amrinone USDMF

A Amrinone DMF (Drug Master File) is a document detailing the whole manufacturing process of Amrinone active pharmaceutical ingredient (API) in detail. Different forms of Amrinone DMFs exist exist since differing nations have different regulations, such as Amrinone USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Amrinone DMF submitted to regulatory agencies in the US is known as a USDMF. Amrinone USDMF includes data on Amrinone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Amrinone USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Amrinone suppliers with USDMF on PharmaCompass.

Amrinone NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Amrinone as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Amrinone API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Amrinone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Amrinone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Amrinone NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Amrinone suppliers with NDC on PharmaCompass.

Amrinone GMP

Amrinone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Amrinone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Amrinone GMP manufacturer or Amrinone GMP API supplier for your needs.

Amrinone CoA

A Amrinone CoA (Certificate of Analysis) is a formal document that attests to Amrinone's compliance with Amrinone specifications and serves as a tool for batch-level quality control.

Amrinone CoA mostly includes findings from lab analyses of a specific batch. For each Amrinone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Amrinone may be tested according to a variety of international standards, such as European Pharmacopoeia (Amrinone EP), Amrinone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Amrinone USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty